CompoAtlas

Equilibre Veineux

Food supplement declared in France, declaration No 2020-8-757

Equilibre Veineux is a food supplement declared in France. Status: retiré du marché le 7 June 2025. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
MICRO-EQUILIBRE
Status
Retiré du marché le 7 June 2025
Form
Gélule
Daily dose
2 gélules
Directions for use
2 gélules par jour avec un verre d'eau
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous anticoagulants, Sous antidépresseurs

Declaration 303650, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Vitis vinifera L.FeuilleExtrait sec aqueux200 mg
Hieracium pilosella L.Plante entièreExtrait sec hydroalcoolique100 mg
Vitis vinifera L.GraineExtrait sec hydroalcoolique80 mg
Ginkgo biloba L.FeuilleExtrait sec hydroalcoolique50 mg
Ruscus aculeatus L.RacineExtrait sec hydroalcoolique30 mg

Other active ingredients

NamePer day
Quercétinenot declared
Bromélaïnenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Bisglycinate de magnésiumMagnésium250 mg300 mg
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
Acétate de D-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E470b

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Consulter votre médecin en cas de prise simultanée d’anticoagulants · L’emploi chez les femmes enceintes et allaitantes et chez les personnes sous antidépresseur est déconseillé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line